Both the U.S. FDA and EU's MDR expect documented risk-based clean room manufacturing environment per ISO 14644-series, ISO 14698-series (and the old FED-STD 209E).
Review a company's clean room manufacturing environment verification and validation practices against industry standards / requirements. What are considered major cGMP deficiencie? Starting with a Master Validation Plan, evaluating its elements against ISO 14971 for hazard analysis and product risk management, allows the development of meaningful clean room manufacturing product quality-specific validations, starting at the desirn stage, through production, to and including de-commissioining. Also the roles of different V&V protocols; Controlled manufacturing, clean room manufacturing, equipment / process DQs, IQs, OQs, and PQs, or their equivalents. Field-tested examples of protocols and specific test cases are provided. Software / firmware V&V using a recently changed FDA software validation "model" are examined, assuring key FDA requirements are not overlooked. The QMS and 21 CFR Part 11 and cybersecurity are considered where required.
Why Should You Attend:FDA Warning Letters and recent high-profile manufacturing contamination issues regarding Covid 19 vacines and infant formula, resuling in some alleged deaths, indicate major cGMP deficiencies in contamination controls with several established manufacturers. What are the regulatory reauirements? The "must have" elements from the CGMPs and international standards for clean rooms, cross-contamination issues, and personnel behavior. Events prove none of these can be taken for granted.
Areas Covered in the Webinar:Participants will learn how effective clean room validation methodologies are a critical requirement in developing and maintaining a compliant clean room manufacturing environment.
Issues to be covered include:
This webinar will provide valuable assistance to all regulated companies that need to review and modify their controlled manufacturing / Clean Room manufacturing environments / facilities. While this presentation is focused on medical devices, many of its principles apply to personnel / companies in the Pharmaceutical, Diagnostic, and Biologics fields, including asceptic fill.
The employees who will benefit include:
John E LincolnPrincipal, J E Lincoln and Associates
John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 36 years’ experience in U.S. FDA-regulated industries, 22 as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. John is a graduate of UCLA.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).
This product hasn't received any reviews yet. Be the first to review this product! Write review
